May 16th, 2022
From the desk of The Editor
Dear Reader,
We have identified several healthtech stocks which are expected to go “Ex-Dividend” starting today May 16th.
If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Lemaitre Vascular
Symbol: LMAT
Recent Price: $$43.29
Average Analyst Price Target: $50.00 (15.51%)
Market Cap: $$950.19M
Expected Ex-Dividend Date: May 16 2022
Expected Payment Date: Jun 02 2022
Expected Dividend & Yield: 1.08%
Recent Analyst Action: Michael Petusky, analyst at Barrington, reiterates coverage on Lemaitre Vascular (LMAT) in the Healthcare sector with a Buy rating and a price target of $ 50 (2 weeks ago).
TipRanks.com also reports that Lemaitre Vascular currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $50.00 . The target pricing ranges from a high forecast of $50.00 down to a low forecast of $50.00. Lemaitre Vascular (LMAT)’s last closing price was $$43.29 which would put the average price target at 15.51% upside.Here are 3rd party ratings for LMAT:
- TipRanks.com: Moderate Buy
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Strong Sell, Bottom 24% (192 out of 253)
--------------------------------------------------------------------------
LifeVantage
Symbol: LFVN
Recent Price: $$4.02
Average Analyst Price Target: $7.00 (74.13%)
Market Cap: $$50.61M
Expected Ex-Dividend Date: May 16 2022
Expected Payment Date: May 31 2022
Expected Dividend & Yield: 0.72%
Recent Analyst Action: Douglas Lane, analyst at Lane Research, reiterates coverage on LifeVantage (LFVN) in the Healthcare sector with a Buy rating and a price target of $ 7 (1 week ago).
TipRanks.com also reports that LifeVantage currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $7.00 . The target pricing ranges from a high forecast of $7.00 down to a low forecast of $7.00. LifeVantage (LFVN)’s last closing price was $$4.02 which would put the average price target at 74.13% upside.Here are 3rd party ratings for LFVN:
- TipRanks.com: Moderate Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: n/a, n/a
--------------------------------------------------------------------------
Laboratory
Symbol: LH
Recent Price: $$244.62
Average Analyst Price Target: $312.20 (27.63%)
Market Cap: $$22.68B
Expected Ex-Dividend Date: May 18 2022
Expected Payment Date: Jun 09 2022
Expected Dividend & Yield: 0.29%
Recent Analyst Action: Eric Coldwell, analyst at Robert W. Baird, reiterates coverage on Laboratory (LH) in the Healthcare sector with a Buy rating and a price target of $ 325 (4 days ago).
TipRanks.com also reports that Laboratory currently has 10 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $312.20 . The target pricing ranges from a high forecast of $350.00 down to a low forecast of $265.00. Laboratory (LH)’s last closing price was $$244.62 which would put the average price target at 27.63% upside.Here are 3rd party ratings for LH:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 15% (215 out of 253)
--------------------------------------------------------------------------
Sea
Symbol: SE
Recent Price: $$75.40
Average Analyst Price Target: $188.35 (149.80%)
Market Cap: $$42.20B
Expected Ex-Dividend Date: n/a
Expected Payment Date: n/a
Expected Dividend & Yield:
Recent Analyst Action: Piyush Choudhary, analyst at HSBC, reiterates coverage on Sea (SE) in the Consumer Goods sector with a Buy rating and a price target of $ 145 (1 week ago).
TipRanks.com also reports that Sea currently has 17 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $188.35 . The target pricing ranges from a high forecast of $295.00 down to a low forecast of $105.00. Sea (SE)’s last closing price was $$75.40 which would put the average price target at 149.80% upside.Here are 3rd party ratings for SE:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 31% (174 out of 253)
--------------------------------------------------------------------------
And there you have it...
Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Sincerely,
The Editor
